Correlation Between Marker Therapeutics and Ginkgo Bioworks

Can any of the company-specific risk be diversified away by investing in both Marker Therapeutics and Ginkgo Bioworks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marker Therapeutics and Ginkgo Bioworks into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Marker Therapeutics and Ginkgo Bioworks Holdings, you can compare the effects of market volatilities on Marker Therapeutics and Ginkgo Bioworks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marker Therapeutics with a short position of Ginkgo Bioworks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marker Therapeutics and Ginkgo Bioworks.

Diversification Opportunities for Marker Therapeutics and Ginkgo Bioworks

-0.04

Correlation Coefficient

Marker Therapeutics  Ginkgo Bioworks

Good diversification

The 3 months correlation between Marker and Ginkgo is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Marker Therapeutics and Ginkgo Bioworks Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ginkgo Bioworks Holdings and Marker Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marker Therapeutics are associated (or correlated) with Ginkgo Bioworks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ginkgo Bioworks Holdings has no effect on the direction of Marker Therapeutics i.e., Marker Therapeutics and Ginkgo Bioworks go up and down completely randomly.

Pair Corralation between Marker Therapeutics and Ginkgo Bioworks

Given the investment horizon of 90 days Marker Therapeutics is expected to under-perform the Ginkgo Bioworks. But the stock apears to be less risky and, when comparing its historical volatility, Marker Therapeutics is 1.01 times less risky than Ginkgo Bioworks. The stock trades about -0.2 of its potential returns per unit of risk. The Ginkgo Bioworks Holdings is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  874.00  in Ginkgo Bioworks Holdings on December 19, 2024 and sell it today you would lose (126.00) from holding Ginkgo Bioworks Holdings or give up 14.42% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Marker Therapeutics  vs.  Ginkgo Bioworks Holdings

Marker Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Marker Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's forward-looking signals remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Ginkgo Bioworks Holdings

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ginkgo Bioworks Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Ginkgo Bioworks is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Marker Therapeutics and Ginkgo Bioworks

The main advantage of trading using opposite Marker Therapeutics and Ginkgo Bioworks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marker Therapeutics position performs unexpectedly, Ginkgo Bioworks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will offset losses from the drop in Ginkgo Bioworks' long position.

The idea behind Marker Therapeutics and Ginkgo Bioworks Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.